Frontlight ResearchEarly access
CompletedNo phase
Glucose Testing in GDM: Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics
Key facts
- Who runs it
- Weill Medical College of Cornell University
- Where
- New York, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 140 people enrolled
- Started
- 15 Jul 2021
- Ended
- 1 May 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- 1 hour Blood glucose monitoring
- 2 hour blood glucose monitoring
- Record updated
- 23 May 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Pregnant patients with singleton gestation who are ≥ 18 years of age
- Diagnosis of GDM after 24 0/7 weeks
- For diagnosing GDM, a two-step screening algorithm will be performed according to the American College of Obstetrics and Gynecologists.4 Specifically, a 1-hour 50-g glucose-loading test is given first. Plasma glucose levels between 140 and 200 mg/dL will be considered elevated. Confirmatory testing will then be performed using a 3-hour 100-g glucose tolerance test. Diagnosis was made when two of the four values were elevated. Abnormal glucose value thresholds are established via the criteria suggested by Carpenter and Coustan: fasting value ≥ 95 mg/dL, 1-hour ≥ 180 mg/dL, 2-hour ≥ 155 mg/dL, and 3-hour ≥ 140 mg/dL.9 Patients with a blood glucose level greater than 200 mg/dL after 1-hour 50-g glucose-loading test will be diagnosed with GDM without requirement for the 3-hour 100-g glucose tolerance test
Who cannot take part
- GDM diagnosed prior to 24 0/7 weeks gestation
- Type 1 pre-gestational diabetes
- Type 2 pre-gestational diabetes
Where in United States
- New York Prebyterian Hospital Weill CornellNew York, United States
About the trial
What the trial wants to find out
The purpose of this study is to evaluate if in patients with gestational diabetes (GDM), adherence to postprandial glucose monitoring differs when performed 1-hour versus 2-hours after eating.
Read full original descriptionShow less
The primary objective of this study is to evaluate difference in rate of adherence (binary outcome defined as <80% or ≥80% of glucose log completed) between gestational diabetics who perform 1-hour versus 2-hour postprandial blood glucose testing.
The 2 groups in the trial
- 1-hour post-prandial blood glucose monitoring ArmOther group
Arm in which participants are randomized to blood glucose monitoring at 1 hour after eating.
Treatment: 1 hour Blood glucose monitoring
- 2-hour post-prandial blood glucose monitoring ArmOther group
Arm in which participants are randomized to blood glucose monitoring at 2 hours after eating.
Treatment: 2 hour blood glucose monitoring
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics: A Randomized Trial
- Record updated
- 23 May 2025